Form D Action: Sequence Bioinformatics $1.60 million Financing. Chris Gardner Filed Jun 28 Form D

Sequence Bioinformatics Inc. - Chris Gardner

Sequence Bioinformatics Financing

Sequence Bioinformatics Inc., Corporation just had published form D for $1.60 million equity financing. This is a new filing. Sequence Bioinformatics was able to fundraise $1.60 million. That is 100.00% of the financing offer. The total private offering amount was $1.60 million. The fundraising form was filed on 2016-06-28. The reason for the financing was: unspecified.

Sequence Bioinformatics is based in Newfoundland – Canada. The company’s business is not disclosed. The form D was filed by Chris Gardner President. The company was incorporated in 2013. The filler’s address is: 30 Harvey Road, St. Johns, A4, Newfoundland, Canada, A1e 2G1. Chris Gardner is the related person in the form and it has address: 30 Harvey Road, St. John’s, A4, Newfoundland, Canada, A1e 2G1. Link to Sequence Bioinformatics Filing: 000167958816000001.

Analysis of Sequence Bioinformatics Offering

On average, startups in the not disclosed sector, sell 67.77% of the total offering size. Sequence Bioinformatics sold 100.00% of the offering. Could this mean that the trust in Sequence Bioinformatics is high? The average financing size for companies in all industries in our database is $3.05 million. The offering was 47.54% smaller than the average of $3.05 million. Of course this should not be taken as negative. Businesses raise funds for different reasons and needs. The minimum investment for this financing was set at $0. If you know more about the reasons for the financing, please comment below.

What is Form D? What It Is Used For

Form D disclosures could be used to track and understand better your competitors. The information in Form D is usually highly confidential for ventures and startups and they don’t like revealing it. This is because it reveals amount raised or planned to be raised as well as reasons for the financing. This could help competitors. Entrepreneurs usually want to keep their financing a ‘secret’ so they can stay in stealth mode for longer.

Why Fundraising Reporting Is Good For Sequence Bioinformatics Also

The Form D signed by Chris Gardner might help Sequence Bioinformatics Inc.’s sector. First, it helps potential customers feel more safe to deal with a firm that is well financed. The odds are higher that it will stay in the business. Second, this could attract other investors such as venture-capital firms, funds and angels. Third, positive PR effects could even bring leasing firms and venture lenders.

Receive News & Ratings Via Email - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings with our FREE daily email newsletter.

Related posts

Leave a Comment